Carlos Rodriguez is a Cardiology physician. ClinicalTrials.gov lists 12 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
C-2 Consolidated Mall Ave. Gautier Benitez
Caguas, PR 007265307
Telephone
787-743-2378Provider last certified this registry record 27 Feb 2024.
Clinical trials
- Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation
Sponsor: University of Las Palmas de Gran Canaria
- Program of Supervised Occlusive Aerobic Training in People With Fibromyalgia.
Sponsor: José Carlos Rodríguez Bautista
- Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma
Sponsor: St. Jude Children's Research Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20254 payments
- Boston Scientific CorporationProgram year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.3%Statin17%Atorvastatin Calcium56%Rosuvastatin Calcium33%Pravastatin Sodium6%Simvastatin5%Lovastatin1%Part D<11 patientsAngiotensin receptor blocker (ARB)12.8%Losartan Potassium45%Candesartan Cilexetil17%Irbesartan12%Losartan-Hydrochlorothiazide10%Candesartan-Hydrochlorothiazid5%Valsartan5%Irbesartan-Hydrochlorothiazide3%Telmisartan2%Valsartan-Hydrochlorothiazide1%Part D<11 patients+ 23 more classes in this area
Metabolism & gastrointestinal
9.5%Biguanide (metformin)2%Metformin Hcl95%Metformin Hcl Er5%Part D<11 patientsProton pump inhibitor1.9%Pantoprazole Sodium63%Omeprazole25%Esomeprazole Magnesium8%Lansoprazole4%Part D<11 patients+ 10 more classes in this area
Blood & clotting
7.9%P2Y12 inhibitor3.4%Clopidogrel90%Brilinta5%Plavix4%Prasugrel Hcl2%Part D<11 patientsFactor Xa inhibitor2.8%Eliquis69%Xarelto31%Part D≥72 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”